Latest Period
Q1 2026
Security Snapshot
Encompass Health Corp - Common Stock (EHC) Institutional Ownership
CUSIP: 29261A100
13F Institutional Holders and Ownership History from Q1 2016 to Q1 2026
Institutions Reporting
574
Shares (Excl. Options)
95,893,166
Price
$96.73
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Common Stock
- Symbol
- EHC on NYSE
- Shares outstanding
- 99,498,517
- Reported price per share
- $107.15
- Price from insider filings
- $107.15
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 95,893,166
- Total reported value
- $9,304,872,880
- Portfolio coverage rank
- 0.01%
- Share change
- -1,320,035
- Value change
- -$154,271,571
- Number of holders
- 574
Security identity
Issuer context
Latest holder snapshot
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- EHC - Encompass Health Corp - Common Stock is tracked under CUSIP 29261A100.
- 574 institutions reported positions in Q1 2026.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 591 to 574 between Q4 2025 and Q1 2026.
- Reported value moved from $10,345,027,833 to $9,304,872,880.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC Evidence
Latest holder context comes from 574 institutions filings for Q1 2026.
Security key
29261A100
Latest holder period
Q1 2026
13F holders
574
13D/G owners
4
CIK / CUSIP context first
Open Q1 2026 holders
EHC full holder history
Encompass Health Corp SEC filings
Encompass Health Corp company facts
Encompass Health Corp insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 29261A100:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
4
Security
EHC
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| VANGUARD CAPITAL MANAGEMENT LLC | 5.3% | $506,248,256 | 5,233,622 | Vanguard Capital Management | 31 Mar 2026 | |||
| Invesco Ltd. | 4.9% | $535,910,573 | 4,972,725 | Invesco Ltd. | 31 Dec 2025 | |||
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5% | $480,902,965 | 4,971,601 | Vanguard Portfolio Management | 31 Mar 2026 | |||
| WELLINGTON MANAGEMENT GROUP LLP | 4% | $456,931,210 | 4,030,442 | Wellington Management Group LLP | 31 Dec 2024 |
As of 31 Mar 2026, 574 institutional investors reported holding 95,893,166 shares of Encompass Health Corp - Common Stock (EHC). This represents 96% of the company’s total 99,498,517 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
62%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| BlackRock, Inc. | 11% | 10,768,713 | +4.5% | 0.02% | $1,041,657,564 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 5% | 4,959,545 | 0% | 0.03% | $479,736,788 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 4.6% | 4,600,549 | -4.3% | 0.05% | $445,012,000 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4.5% | 4,466,237 | 0% | 0.01% | $432,019,105 |
| WELLINGTON MANAGEMENT GROUP LLP | 3.9% | 3,848,855 | +14% | 0.07% | $372,299,745 |
| Invesco Ltd. | 3.4% | 3,386,105 | -32% | 0.05% | $327,537,957 |
| T. Rowe Price Investment Management, Inc. | 3.2% | 3,228,026 | +19% | 0.22% | $312,247,000 |
| STATE STREET CORP | 3.2% | 3,144,974 | +1.8% | 0.01% | $304,213,335 |
| ALLIANCEBERNSTEIN L.P. | 2.6% | 2,621,245 | +40% | 0.09% | $278,218,944 |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2.2% | 2,229,979 | +8.6% | 0.73% | $215,705,840 |
| TWO SIGMA INVESTMENTS, LP | 2.2% | 2,222,101 | +176% | 0.18% | $214,943,830 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.9% | 1,898,667 | -2.4% | 0.01% | $183,703,287 |
| GOLDMAN SACHS GROUP INC | 1.8% | 1,805,721 | +300% | 0.02% | $174,667,394 |
| DIMENSIONAL FUND ADVISORS LP | 1.7% | 1,674,784 | +3.1% | 0.03% | $162,013,300 |
| JPMORGAN CHASE & CO | 1.2% | 1,231,471 | +12% | 0.01% | $120,093,116 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.2% | 1,182,574 | +1.6% | 0.06% | $114,390,383 |
| RAYMOND JAMES FINANCIAL INC | 1.1% | 1,067,006 | -22% | 0.03% | $103,574,729 |
| NORTHERN TRUST CORP | 0.96% | 958,198 | +0.91% | 0.01% | $92,686,492 |
| Sumitomo Mitsui Trust Group, Inc. | 0.93% | 929,348 | -8% | 0.06% | $89,895,832 |
| MORGAN STANLEY | 0.9% | 896,982 | -2.4% | 0.01% | $86,765,289 |
| Copeland Capital Management, LLC | 0.9% | 892,823 | +17% | 1.9% | $86,362,891 |
| Bank of New York Mellon Corp | 0.87% | 865,542 | -2.3% | 0.02% | $83,723,883 |
| BANK OF AMERICA CORP /DE/ | 0.87% | 862,512 | -10% | 0.01% | $83,430,786 |
| FRANKLIN RESOURCES INC | 0.85% | 843,802 | -6.4% | 0.02% | $81,620,968 |
| Qube Research & Technologies Ltd | 0.84% | 839,807 | -12% | 0.12% | $81,234,531 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
41
Latest
Q1 2026
Rows shown
1-25 of 41
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 95,893,166 | $9,304,872,880 | -$154,271,571 | $96.73 | 574 |
| 2025 Q4 | 97,435,596 | $10,345,027,833 | +$354,136,059 | $106.14 | 591 |
| 2025 Q3 | 93,686,723 | $11,896,053,253 | -$135,234,226 | $127.02 | 603 |
| 2025 Q2 | 94,968,235 | $11,642,879,160 | -$49,112,078 | $122.63 | 603 |
| 2025 Q1 | 95,615,973 | $9,683,390,579 | +$19,223,151 | $101.28 | 534 |
| 2024 Q4 | 95,688,892 | $8,837,272,246 | -$61,337,557 | $92.35 | 540 |
| 2024 Q3 | 95,659,986 | $9,240,740,107 | -$28,092,689 | $96.64 | 478 |
| 2024 Q2 | 95,815,590 | $8,220,005,999 | -$60,422,230 | $85.79 | 476 |
| 2024 Q1 | 97,703,422 | $8,070,672,559 | +$16,673,851 | $82.58 | 433 |
| 2023 Q4 | 97,223,556 | $6,487,871,907 | +$126,291,067 | $66.72 | 429 |
| 2023 Q3 | 94,211,639 | $6,326,664,657 | +$24,828,296 | $67.16 | 410 |
| 2023 Q2 | 93,484,125 | $6,330,038,243 | +$9,034,551 | $67.71 | 380 |
| 2023 Q1 | 93,612,402 | $5,065,388,681 | -$121,237,618 | $54.10 | 384 |
| 2022 Q4 | 96,070,844 | $5,746,729,705 | +$9,797,176 | $59.81 | 368 |
| 2022 Q3 | 96,958,614 | $4,388,175,997 | +$140,328,300 | $45.23 | 325 |
| 2022 Q2 | 91,599,655 | $5,129,979,182 | -$75,940,650 | $56.05 | 367 |
| 2022 Q1 | 94,188,292 | $6,688,146,207 | +$180,281,875 | $71.11 | 399 |
| 2021 Q4 | 91,512,815 | $5,963,921,386 | -$30,961,306 | $65.26 | 397 |
| 2021 Q3 | 91,185,917 | $6,852,134,068 | -$52,652,075 | $75.04 | 430 |
| 2021 Q2 | 91,493,382 | $7,141,491,218 | +$213,843 | $78.03 | 409 |
| 2021 Q1 | 92,312,962 | $7,562,692,331 | +$3,926,033 | $81.90 | 398 |
| 2020 Q4 | 92,274,413 | $7,632,521,664 | -$63,397,436 | $82.69 | 396 |
| 2020 Q3 | 92,464,254 | $6,004,059,199 | +$39,210,352 | $64.98 | 367 |
| 2020 Q2 | 91,927,091 | $5,693,124,070 | +$51,792,099 | $61.93 | 368 |
| 2020 Q1 | 91,105,048 | $5,833,264,260 | +$52,464,250 | $64.03 | 364 |